Shaw and Tomljenovich: Estimates of HPV Vaccine Safety and Efficacy
Posted Aug 01 2012 9:33am
Christopher Shaw and Lucija Tomljenovic have once again hit the nail on the head when it comes to revealing the truth behind HPV vaccination policies and practices. In a recent letter to the editor of the American Journal of Public Health, they disclose that when comparing the adverse events reported after Gardasil to all other vaccines in the targeted age group, Gardasil alone is associated with over 60% of all serious adverse reactions in the VAERS database, including over 80% of all permanent disabilities. As a parent, are you willing to have your daughter risk permanent disability or death to take a vaccine that has not been proven to prevent a single case of cervical cancer? ]
Who Profits From Uncritical Acceptance of Biased Estimates of Vaccine Efficacy and Safety?
At the time of the writing, Lucija Tomljenovic and Christopher A. Shaw were with the Neural Dynamics Research Group, University of British Columbia, Vancouver, Canada.
We read with great interest the analysis by Mello et al.(1) on how Merck & Co., Inc. (Merck) influenced state human papillomavirus (HPV) vaccination policymaking. The exclusive reliance on Merck for scientific information on behalf of the legislators is unfortunate, especially in the light of independent research which has repeatedly warned that drug companies may manipulate clinical trial designs and subsequent data analysis and reporting to make their drugs look better and safer.(2-4) Indeed, careful scrutiny of Gardasil clinical trials shows that their design, as well as data reporting and interpretation, were largely inadequate.(4-6) (Am J Public Health. Published online ahead of print July 19, 2012: e1-e2. doi:10.2105/AJPH.2012.300837).